Patents by Inventor Karin Rapp

Karin Rapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions
    Patent number: 10188696
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: January 29, 2019
    Assignees: Novartis AG, Debiopharma S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160367624
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: May 12, 2016
    Publication date: December 22, 2016
    Applicants: Novartis AG, DEBIOPHARM S.A.
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140005123
    Abstract: The invention provides lipid-based pharmaceutical compositions comprising alisporivir.
    Type: Application
    Filed: December 12, 2011
    Publication date: January 2, 2014
    Applicants: DEBIOPHARM S.A., NOVARTIS AG
    Inventors: Elisabete Goncalves, Karin Rapp, Bertrand Sutter, Frank Stowasser, Bjoern Trupp, Sebastian Chabaut, Julien Thorens
  • PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS
    Publication number: 20110021530
    Abstract: Methods of treating an SCD-mediated skin disorder or condition in a mammal, preferably a human, including administering to a mammal in need thereof a compound of formula (I): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein, and compositions including a compound of formula (I).
    Type: Application
    Filed: February 19, 2009
    Publication date: January 27, 2011
    Applicants: XENON PHARMACEUTICALS INC., NOVARTIS AG
    Inventors: Andreas Billich, Michael D. Winther, Yigal Paul Goldberg, Gesine Winzenburg, Karin Rapp, Andreas Fritze